NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/14/2024
Back to search
Official data from USPTO
DCVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/14/2024
Trademark type
Word
Nice classes
5
Filing date
06/03/2014
Registration date
11/14/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
03/06/2002
First use in commerce
03/06/2002
Drawing code
4
Owner type
03
Owner location
Bethesda, MD
Examiner
ORNDORFF, LINDA
Law office
M20
Current location
TMO LAW OFFICE 111
Holders and representatives
Holders
Northwest Biotherapeutics, Inc.
Representatives
Melissa A. Nowak Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Immune cellsnamely cells for medical or veterinary use; Biotechnology preparations for the preventionmanagement and treatment of cancerfor the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extenttiming or duration of the immune response or changing the nature of the immune response; Medical preparations for the preventionmanagement and treatment of cancerfor the modulation of the immune system or particular elements of the immune system by increasing or decreasing the extenttiming or duration of the immune response or changing the nature of the immune response; Pharmaceutical preparations and substances for use as vaccine adjuvantsimmune system stimulators or suppressorsimmune system modulators; Derivatives and modulators of immune cellsvaccinesproteinspeptidesenzymescytokineschemokinesantibodiesDNARNAgrowth factorscell lysateextracellular matrix and conditioned media for medical or veterinary use; Vaccines
Publications
History of USPTO decisions and trademark events.
28 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/14/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/14/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/10/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/06/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/14/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/29/2017
PUBO
PUBLISHED FOR OPPOSITION
08/29/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/25/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/21/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/28/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/28/2016
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/28/2016
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/25/2015
ALIE
ASSIGNED TO LIE
09/25/2015
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/23/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/17/2014
GNSL
LETTER OF SUSPENSION E-MAILED
09/17/2014
CNSL
SUSPENSION LETTER WRITTEN
09/17/2014
DOCK
ASSIGNED TO EXAMINER
09/16/2014
MPMK
NOTICE OF PSEUDO MARK E-MAILED
06/17/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/16/2014
NWAP
NEW APPLICATION ENTERED
06/06/2014
Continuous trademark protection
Get notified about every new filing that threatens DCVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.